Bohring-Opitz syndrome (BOS) is a severe congenital disorder associated with de novo mutations in the Additional sex combs-like 1 (ASXL1) gene, characterized by symptoms that include developmental delay and musculoskeletal and neurological features (Hastings et al., 2011). The gene discussed is ASXL1; the disease is Buschke-Ollendorff syndrome.